Dr. Reni Butler speaks with Dr. Qiuyi Fu and Dr. Weimin Chai about their research evaluating photon-counting CT for pre-treatment breast cancer assessment and how the technology compares with mammography, MRI, and PET CT for tumor characterization, staging, and lesion detection. Drawing from their prospective study, they explore photon-counting CT's potential advantages in measuring tumor extent, detecting nodal metastases, and advancing the future of breast imaging.